Head to head
Crocs vs Nike
Side-by-side on the measures that matter, with a plain-English read. Full detail: CROX · NKE
CROX
Crocs
154.67-1.68%
1-year price shape — +97% over the period
Quant Rating C · 97/100
vs
NKE
Nike
32.92-4.11%
1-year price shape — -45% over the period
Quant Rating E · 7/100
1-year performance, rebased to 100
Nike edges it on the scoreable measures. Nike pays the highest dividend yield; Nike earns the most per share.
| CROX | NKE | |
|---|---|---|
| Snapshot | ||
| Sector | Footwear & Accessories | Footwear & Accessories |
| Last price | 154.67 | 32.92 |
| Change today | -1.68% | -4.11% |
| 1-year return | +97.0% | -44.6% |
| Market cap | $7.07B | $48.90B |
| 52-week range | 75.13 – 164.24 | 31.97 – 67.36 |
| Valuation | ||
| P/E (TTM) | 11.72 | 15.75 |
| P/E percentile, own 5-yr range | 81st | 0th |
| P/B | 5.26 | 3.21 |
| Dividend yield | 0.00% | 4.98% |
| Profitability & growth | ||
| EPS (TTM) | -1.50 | 2.10 |
| Net profit (TTM) | $-68.59M | $3.12B |
| Revenue (TTM) | $4.10B | $45.89B |
| Provider revenue period date | 2026-09-29 | 2026-08-30 |
| Revenue growth (YoY) | +4.6% | -4.3% |
| Gross margin | 59.4% | 43.1% |
| Operating margin | 22.6% | 8.2% |
| Net margin | 16.2% | 6.7% |
| Free cash flow (TTM) | $753.99M | $2.11B |
| Provider cash-flow period date | 2026-09-29 | 2026-08-30 |
| Ownership & sentiment | ||
| Institutional ownership | 108.7% | 67.1% |
| Insider activity (12mo) | 26 buy / 23 sell | 26 buy / 23 sell |
| Short interest (% of float) | 9.5% | 6.3% |
| Analyst consensus | 50% buy / 40% hold / 10% sell (10) | 28% buy / 44% hold / 28% sell (32) |
| Analyst price target | $160 (+3%) | $39 (+17%) |
| StockVane view | ||
| StockVane Quant Rating | C (97) | E (7) |
| Company | ||
| Employees | 8,010 | 73,000 |
| Founded | 2002 | 1967 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.